Cargando…

Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition

Clinical practice guidelines (CPGs) consist of clinical questions (CQs) and corresponding recommendations. Considering the estimation of body of evidence, patients’ opinions, and medical economics, recommendations can vary depending on the votes of the committee members of CPGs. Taking this into con...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisatome, Ichiro, Hamada, Toshihiro, Mizuta, Einosuke, Ohtahara, Akira, Kuwabara, Masanari, Ogino, Kazuhide, Ninomiya, Haruaki, Sato, Yasuto, Nakayama, Takeo, Yamanaka, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628237/
https://www.ncbi.nlm.nih.gov/pubmed/37941684
http://dx.doi.org/10.31662/jmaj.2023-0067
_version_ 1785131713088716800
author Hisatome, Ichiro
Hamada, Toshihiro
Mizuta, Einosuke
Ohtahara, Akira
Kuwabara, Masanari
Ogino, Kazuhide
Ninomiya, Haruaki
Sato, Yasuto
Nakayama, Takeo
Yamanaka, Hisashi
author_facet Hisatome, Ichiro
Hamada, Toshihiro
Mizuta, Einosuke
Ohtahara, Akira
Kuwabara, Masanari
Ogino, Kazuhide
Ninomiya, Haruaki
Sato, Yasuto
Nakayama, Takeo
Yamanaka, Hisashi
author_sort Hisatome, Ichiro
collection PubMed
description Clinical practice guidelines (CPGs) consist of clinical questions (CQs) and corresponding recommendations. Considering the estimation of body of evidence, patients’ opinions, and medical economics, recommendations can vary depending on the votes of the committee members of CPGs. Taking this into consideration, concerns have already been raised on how financial conflict of interest (COI) potentially influences recommendations. In this study, we developed the third edition of guideline for the management of hyperuricemia and gout. This CPG was composed of seven CQs and recommendations. The direction and strength of the recommendations were determined by votes. There are three CQs. Individual questions asked whether uric acid-lowering-agents (ULAs) could be applied to hyperuricemic patients with chronic kidney disease (CKD) (CQ A), hypertension (CQ B), or heart failure (CQ C) to prevent organ damage. We examined whether the absence (18 members) or presence (8 members) of COIs of committee members could influence the votes. In total, 26 committee members with and without COI have equally determined the direction and strength of recommendations. In CQ A, members without financial COIs and those with financial COI selected conditional recommendation for the use of ULAs in patients with CKD (without COI, 17/18; with COI, 7/8). In CQ B, members without financial COIs and those with financial COI selected conditional recommendation against the use of ULAs in hypertensive patients (without COI, 14/18; with COI, 5/8). In CQ C, members without financial COIs and those with financial COIs have selected conditional recommendation against the use of ULAs in patients suffering from heart failure (without COI, 15/18; with COI, 4/8). We found that members with financial COIs have determined their recommendations in the same direction and strength as those without financial COIs.
format Online
Article
Text
id pubmed-10628237
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japan Medical Association
record_format MEDLINE/PubMed
spelling pubmed-106282372023-11-08 Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition Hisatome, Ichiro Hamada, Toshihiro Mizuta, Einosuke Ohtahara, Akira Kuwabara, Masanari Ogino, Kazuhide Ninomiya, Haruaki Sato, Yasuto Nakayama, Takeo Yamanaka, Hisashi JMA J Opinion Clinical practice guidelines (CPGs) consist of clinical questions (CQs) and corresponding recommendations. Considering the estimation of body of evidence, patients’ opinions, and medical economics, recommendations can vary depending on the votes of the committee members of CPGs. Taking this into consideration, concerns have already been raised on how financial conflict of interest (COI) potentially influences recommendations. In this study, we developed the third edition of guideline for the management of hyperuricemia and gout. This CPG was composed of seven CQs and recommendations. The direction and strength of the recommendations were determined by votes. There are three CQs. Individual questions asked whether uric acid-lowering-agents (ULAs) could be applied to hyperuricemic patients with chronic kidney disease (CKD) (CQ A), hypertension (CQ B), or heart failure (CQ C) to prevent organ damage. We examined whether the absence (18 members) or presence (8 members) of COIs of committee members could influence the votes. In total, 26 committee members with and without COI have equally determined the direction and strength of recommendations. In CQ A, members without financial COIs and those with financial COI selected conditional recommendation for the use of ULAs in patients with CKD (without COI, 17/18; with COI, 7/8). In CQ B, members without financial COIs and those with financial COI selected conditional recommendation against the use of ULAs in hypertensive patients (without COI, 14/18; with COI, 5/8). In CQ C, members without financial COIs and those with financial COIs have selected conditional recommendation against the use of ULAs in patients suffering from heart failure (without COI, 15/18; with COI, 4/8). We found that members with financial COIs have determined their recommendations in the same direction and strength as those without financial COIs. Japan Medical Association 2023-09-25 2023-10-16 /pmc/articles/PMC10628237/ /pubmed/37941684 http://dx.doi.org/10.31662/jmaj.2023-0067 Text en Copyright © Japan Medical Association https://creativecommons.org/licenses/by/4.0/JMA Journal is an Open Access journal distributed under the Creative Commons Attribution 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Hisatome, Ichiro
Hamada, Toshihiro
Mizuta, Einosuke
Ohtahara, Akira
Kuwabara, Masanari
Ogino, Kazuhide
Ninomiya, Haruaki
Sato, Yasuto
Nakayama, Takeo
Yamanaka, Hisashi
Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition
title Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition
title_full Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition
title_fullStr Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition
title_full_unstemmed Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition
title_short Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition
title_sort comparison of recommendations made by committee members with and without financial conflict of interest on japanese guideline of treatment of hyperuricemia and gout, third edition
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628237/
https://www.ncbi.nlm.nih.gov/pubmed/37941684
http://dx.doi.org/10.31662/jmaj.2023-0067
work_keys_str_mv AT hisatomeichiro comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT hamadatoshihiro comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT mizutaeinosuke comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT ohtaharaakira comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT kuwabaramasanari comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT oginokazuhide comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT ninomiyaharuaki comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT satoyasuto comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT nakayamatakeo comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition
AT yamanakahisashi comparisonofrecommendationsmadebycommitteememberswithandwithoutfinancialconflictofinterestonjapaneseguidelineoftreatmentofhyperuricemiaandgoutthirdedition